Skip to Main Content

Author Details

Boyd L Yount
University of North Carolina at Chapel Hill
1993
113
52
PMIDPaper TitleJournal TitlePublished Year
36914616A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity.Nat Commun2023
37756379A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus.Sci Transl Med2023
37961507Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus.Res Sq2023
37909048Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination.Cell Host Microbe2023
37800919Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2.mBio2023
37749254Host range, transmissibility and antigenicity of a pangolin coronavirus.Nat Microbiol2023
37425890Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential.bioRxiv2023
35018375Host kinase CSNK2 is a target for inhibition of pathogenic β-coronaviruses including SARS-CoV-2.bioRxiv2022
35476513Genomewide CRISPR knockout screen identified PLAC8 as an essential factor for SADS-CoVs infection.Proc Natl Acad Sci U S A2022
35723434Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses.ACS Chem Biol2022
36097511Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice.ACS Omega2022
33469219Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.Nature2021
33758837Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.bioRxiv2021
33532765Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice.bioRxiv2021
33778258Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: <i>In Vitro</i> Activity against SARS-CoV-2 and Potential Mechanisms.ACS Omega2021
34981062Vandetanib Reduces Inflammatory Cytokines and Ameliorates COVID-19 in Infected Mice.bioRxiv2021
34214046Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.Science2021
34289384Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice.Cell Rep2021
33948590A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice.bioRxiv2021
32511392Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.bioRxiv2020
31801868Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection.J Virol2020
33027653Antigenic Variation of the Dengue Virus 2 Genotypes Impacts the Neutralization Activity of Human Antibodies in Vaccinees.Cell Rep2020
33046644Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection.Proc Natl Acad Sci U S A2020
33299990Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms.bioRxiv2020
32661400Author Correction: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.Nat Med2020
32854108A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures.Nature2020
32668216Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice.Cell Rep2020
32526206SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.Cell2020
32150576Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry.PLoS Pathog2020
32289501Virus-Host Interactions Between Nonsecretors and Human Norovirus.Cell Mol Gastroenterol Hepatol2020
32511406A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures.bioRxiv2020
30355694Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.J Virol2019
31530669Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.mBio2019
30895307Beyond Neutralizing Antibody Levels: The Epitope Specificity of Antibodies Induced by National Institutes of Health Monovalent Dengue Virus Vaccines.J Infect Dis2019
30914508Antagonism of dsRNA-Induced Innate Immune Pathways by NS4a and NS4b Accessory Proteins during MERS Coronavirus Infection.mBio2019
29481552Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes.PLoS Pathog2018
29800370Analyzing the Human Serum Antibody Responses to a Live Attenuated Tetravalent Dengue Vaccine Candidate.J Infect Dis2018
29976657Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines.J Virol2018
30393776Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform.Commun Biol2018
30541777The Human Sodium Iodide Symporter as a Reporter Gene for Studying Middle East Respiratory Syndrome Coronavirus Pathogenesis.mSphere2018
30380413Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization.Cell Rep2018
29746837An Immunocompetent Mouse Model of Zika Virus Infection.Cell Host Microbe2018
29540599Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.J Virol2018
29789360Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles.mBio2018
28830941MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis.mBio2017
28251184Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone.mSphere2017
28377531Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus.mBio2017
28270583A Reverse Genetics Platform That Spans the Zika Virus Family Tree.mBio2017
28490591Deletion of a 197-Amino-Acid Region in the N-Terminal Domain of Spike Protein Attenuates Porcine Epidemic Diarrhea Virus in Piglets.J Virol2017
29152578Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.mSphere2017
  • 1 - 50 of 113

Recommended Authors

Thomas Vallet
Institut Pasteur, Center for the Viral Populations and Pathogenesis
Career Start Year 2017
Number of shared co-authors 4
Mir M Khalid
Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 5
Veronica V Rezelj
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Career Start Year 2015
Number of shared co-authors 4
Chengjin Ye
Texas Biomedical Research Institute
Career Start Year 2013
Number of shared co-authors 1
Brook E Heaton
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 2
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 5
Xuping Xie
University of Texas Medical Branch
Career Start Year 2010
Number of shared co-authors 11
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 5
James Zengel
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 3
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2010
Number of shared co-authors 5
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 5
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 5
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 7
Emmie de Wit
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 9
Natalie J Thornburg
Centers for Disease Control and Prevention (CDC)
Career Start Year 2003
Number of shared co-authors 14
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 11
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 10
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 15
Ian Goodfellow
University of Cambridge
Career Start Year 1996
Number of shared co-authors 3
Larissa B Thackray
Washington University School of Medicine
Career Start Year 1996
Number of shared co-authors 27
Benhur Lee
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 8
Isabel Sola
Campus Universidad Autonoma de Madrid
Career Start Year 1995
Number of shared co-authors 2
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 6
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 1
Chien-Te K Tseng
The University of Texas Medical Branch
Career Start Year 1991
Number of shared co-authors 24
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 10
Charles M Rice
Rockefeller University
Career Start Year 1981
Number of shared co-authors 20
Raul Andino
University of California san francisco
Career Start Year 1981
Number of shared co-authors 7
Luis Enjuanes
Campus Universidad Autonoma de Madrid
Career Start Year 1971
Number of shared co-authors 5

Collaborators

Ralph S Baric
University of North Carolina
Co-authored papers 112
Rachel L Graham
University of North Carolina
Co-authored papers 21
Amy C Sims
The University of North Carolina at Chapel Hill
Co-authored papers 19
Vineet D Menachery
University of Texas Medical Branch
Co-authored papers 17
Lisa E Gralinski
University of North Carolina at Chapel Hill
Co-authored papers 17
Sarah R Leist
University of North Carolina at Chapel Hill
Co-authored papers 16
Sudhakar Agnihothram
National Center for Toxicological Research
Co-authored papers 14
Eric F Donaldson
Co-authored papers 14
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 13
Scott H Randell
Co-authored papers 11
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Co-authored papers 10
Mark R Denison
Vanderbilt University Medical Center
Co-authored papers 9
Matthew B Frieman
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers 9
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Co-authored papers 9
Ande West
University of North Carolina at Chapel Hill
Co-authored papers 7
Raymond J Pickles
Marsico Lung Institute, University of North Carolina-Chapel Hill
Co-authored papers 6
Jessica A Plante
Co-authored papers 6
James E Crowe
Vanderbilt University Medical Center
Co-authored papers 5
Susan E Burkett
Co-authored papers 4
Katrina M Waters
Pacific Northwest National Laboratory
Co-authored papers 4
Hugh D Mitchell
Pacific Northwest National Laboratory (PNNL)
Co-authored papers 4
Yize Li
Co-authored papers 3
Barton F Haynes
Co-authored papers 3
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Co-authored papers 3
Michael G Katze
University of Washington
Co-authored papers 3
Alan C Whitmore
University of North Carolina at Chapel Hill
Co-authored papers 3
Jane C Schroeder
Co-authored papers 2
Stuart Weston
University of Maryland School of Medicine
Co-authored papers 2
Kelly G Stratton
Pacific Northwest National Laboratory
Co-authored papers 2
Andrew F Olshan
Co-authored papers 2
Release 1.2